Vynleads (VYND) Debt to Equity (2020 - 2021)
Vynleads (VYND) posted Debt to Equity of -$0.02 for Q1 2021, up 10.92% on a QoQ basis from -$0.03 in Q4 2020.
Vynleads (VYND) Debt to Equity (2020 - 2021) Analysis & Trends
Vynleads (VYND) has reported Debt to Equity for 2 consecutive years, with -$0.02 the latest figure, recorded in Q1 2021.
- For the quarter ending Q1 2021, Debt to Equity changed N/A year-over-year to -$0.02; the trailing twelve-month figure through Mar 2021 stood at -$0.02 (changed N/A YoY), and the FY2020 full-year result was -$0.03, changed N/A from the prior year.
- Debt to Equity grew to -$0.02 in Q1 2021 per VYND's latest filing, from -$0.03 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.02 in Q1 2021 to a low of -$0.03 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 1.26 |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 0.46 |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | - |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | - |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 0.37 |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | - |
| 10 | Vynleads | - | - | -2,028.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -0.02 |
| Dec 31, 2020 | -0.03 |